Echocardiography during the coronavirus disease 2019 pandemic - the impact of the vaccination program. A 2021 update of the expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society.


Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
2021
Historique:
received: 08 06 2021
accepted: 08 06 2021
entrez: 14 6 2021
pubmed: 15 6 2021
medline: 22 6 2021
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic resulted in an urgent need to reorganize the work of echocardiography laboratories in order to ensure the safety of patients and the protection of physicians, technicians, and other staff members. In the previous Expert Opinion of the Working Group on Echocardiography of Polish Cardiac Society we provided recommendations for the echocardiographic services, in order to ensure maximum possible safety and efficiency of imagers facing epidemic threat. Now, with much better knowledge and larger experience in treating COVID-19 patients and with introduction of vaccination programs, we present updated recommendations for performing transthoracic and transesophageal examinations, including information on the potential impact of personnel and the patient vaccination program, and growing numbers of convalescents on performance of echocardiographic laboratories, with the goal of their ultimate reopening.

Identifiants

pubmed: 34125943
pii: VM/OJS/J/84107
doi: 10.33963/KP.15973
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-603

Auteurs

Piotr Szymański (P)

Clinical Cardiology Center, Central Clinical Hospital of the Ministry of the Interior in Warsaw and Center of Postgraduate Medical Education, Warszawa, Poland. pszymanski@ptkardio.pl.

Andrzej Gackowski (A)

Jagiellonian University, Medical College, Institute of Cardiology, Department of Coronary Disease and Heart Failure, Noninvasive Cardiovascular Laboratory, John Paul II Hospital, Kraków, Poland.

Katarzyna Mizia-Stec (K)

1st Department of Cardiology, Medical University of Silesia in Katowice, Katowice, Poland.

Jarosław D Kasprzak (JD)

1st Department of Cardiology, Medical University of Lodz, Bieganski Hospital, Łódź, Poland.

Magdalena Lipczyńska (M)

Department of Congenital Heart Disease, National Institute of Cardiology, Warszawa, Poland.

Piotr Lipiec (P)

Department of Rapid Cardiac Diagnostics, Medical University of Lodz, Łódź, Poland.

Olga Trojnarska (O)

1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.

Paulina Wejner-Mik (P)

1st Department of Cardiology, Medical University of Lodz, Bieganski Hospital, Łódź, Poland.

Danuta Sorysz (D)

Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.

Bożena Sobkowicz (B)

Department of Cardiology, Medical University in Bialystok, Białystok, Poland.

Zofia Oko-Sarnowska (Z)

1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.

Andrzej Wysokiński (A)

Department of Cardiology, Pomeranian Medical University, Szczecin, Poland.

Andrzej Szyszka (A)

2nd Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.

Edyta Płońska-Gościniak (E)

Department of Cardiology, Medical University of Lublin, Lublin, Poland.

Zbigniew Gąsior (Z)

Department of Cardiology, Medical University of Silesia in Katowice, Katowice, Poland.

Michał Ciurzyński (M)

Department of Internal Medicine and Cardiology Medical University of Warsaw, Warszawa, Poland.

Tomasz Pasierski (T)

Department of Medical Ethics and Palliative Medicine, Warsaw Medical University, Warszawa, Poland.

Piotr Hoffman (P)

Department of Congenital Heart Disease, National Institute of Cardiology, Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH